Vadodara-based Ami Lifesciences, a pure-play manufacturer and exporter of Active Pharmaceutical Ingredients (API) and intermediates to leading pharmaceutical companies of the world, has announced the appointment of Amit Kaptain as Chief Executive Officer (CEO) of the company.

As part of the Ami Lifesciences senior management team, Kaptain will be responsible for building business strategy & longstanding global partnerships with leading pharmaceutical companies (including Big Pharma and Innovators) by developing products in niche therapeutic areas, and thereby becoming a reliable partner of choice from India.

With 20+ years of experience in the API industry, Kaptain is a seasoned professional in driving sales, marketing and operations across global markets and has worked with large Indian MNCs such as Dr. Reddy’s, Ranbaxy, and Sun Pharma.

Prior to joining Ami Lifesciences, he worked as COO at Aurore Lifesciences. Prior to that Kaptain worked at Dr. Reddy’s (DRL) for 7 years in various leadership roles and managed one of the top 10 P&L’s in the API industry globally. At DRL, he was also responsible for product portfolio & strategy, customer service and new market development.

At Ranbaxy, Kaptain was Head of Global API Sales & Marketing and was responsible for driving new product development. He spent ~6 years with Sun Pharma where he was responsible for sales & marketing in India, Far & South-East Asia.